Free Trial

Hikma Pharmaceuticals (HKMPF) Short Interest Ratio & Short Volume

Hikma Pharmaceuticals logo
$27.73 0.00 (0.00%)
As of 07/1/2025

Hikma Pharmaceuticals Short Interest Data

Hikma Pharmaceuticals (HKMPF) has a short interest of 349,300 shares, representing 0.16% of the float (the number of shares available for trading by the public). This marks a -46.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 873.3, indicating that it would take 873.3 days of the average trading volume of 100 shares to cover all short positions.

Current Short Interest
349,300 shares
Previous Short Interest
648,600 shares
Change Vs. Previous Month
-46.15%
Dollar Volume Sold Short
$9.69 million
Short Interest Ratio
873.3 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
221,890,000 shares
Short Percent of Float
0.16%
Today's Trading Volume
1 shares
Average Trading Volume
100 shares
Today's Volume Vs. Average
1%
Short Selling Hikma Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HKMPF Short Interest Over Time

HKMPF Days to Cover Over Time

HKMPF Percentage of Float Shorted Over Time

Hikma Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/2025349,300 shares $9.69 million -46.2%0.2%873.3 $27.73
5/31/2025648,600 shares $17.99 million -3.4%0.3%6486 $27.73
5/15/2025671,400 shares $18.08 million -4.5%0.3%6714 $26.93
4/30/2025702,800 shares $18.41 million -1.0%N/A0 $26.20
4/15/2025709,600 shares $18.59 million -3.7%0.3%1419.2 $26.20
3/31/2025736,500 shares $19.29 million +4.4%0.3%2455 $26.20
3/15/2025705,400 shares $18.20 million +1.6%0.3%1007.7 $25.80
2/28/2025694,500 shares $18.87 million -6.7%0.3%330.7 $27.17
2/15/2025744,500 shares $20.95 million -32.5%0.3%7445 $28.14
1/31/20251,103,100 shares $29.39 million -3.2%N/A3677 $26.64
1/15/20251,139,700 shares $28.03 million +0.7%N/A1036.1 $24.59
12/31/20241,132,100 shares $27.31 million -26.1%N/A5660.5 $24.12
12/15/20241,531,300 shares $38.08 million +0.6%N/A1276.1 $24.87
11/30/20241,522,000 shares $37.24 million -0.3%N/A15220 $24.47
11/15/20241,526,800 shares $34.44 million +1.1%N/A15268 $22.56
10/31/20241,509,700 shares $37.85 million -2.9%N/A0 $25.07
10/15/20241,554,200 shares $39.10 million +0.7%N/A15542 $25.16
9/30/20241,544,100 shares $39.68 million -0.3%N/A15441 $25.70
9/15/20241,547,900 shares $39.78 million +0.4%N/A15479 $25.70
8/31/20241,541,500 shares $40.02 million -2.1%N/A2202.1 $25.96
8/15/20241,574,300 shares $41.04 million -17.0%N/A1211 $26.07
7/31/20241,896,300 shares $45.51 million +0.2%N/A3792.6 $24.00
7/15/20241,892,500 shares $44.86 million +0.1%N/A6308.3 $23.70
6/30/20241,891,200 shares $47.75 million +1.0%N/A18912 $25.25
6/15/20241,872,400 shares $47.28 million +0.5%N/A3744.8 $25.25
5/31/20241,862,300 shares $45.63 million -0.1%N/A18623 $24.50
5/15/20241,863,300 shares $45.65 million +0.7%N/A6211 $24.50
4/30/20241,849,700 shares $41.30 million +6.2%N/A9248.5 $22.33
4/15/20241,741,900 shares $42.24 million 0.0%N/A5806.3 $24.25
3/31/20241,742,100 shares $40.71 million +0.2%N/A8710.5 $23.37
3/15/20241,739,000 shares $40.64 million 0.0%N/A8695 $23.37
2/29/20241,739,100 shares $46.09 million +0.1%N/A5797 $26.50
2/15/20241,737,700 shares $43.44 million -1.2%N/A2172.1 $25.00
1/15/20241,756,000 shares $43.30 million No ChangeN/A8780 $24.66
12/31/20231,756,000 shares $40.01 million -10.0%N/A2676.8 $22.79
12/15/20231,951,100 shares $43.02 million +0.1%N/A19511 $22.05
11/30/20231,948,900 shares $42.95 million +0.3%N/A721.8 $22.04
11/15/20231,944,100 shares $43.28 million +0.5%N/A4860.3 $22.26
10/31/20231,934,300 shares $45.24 million +4.5%N/A4835.8 $23.39
10/15/20231,850,400 shares $46.97 million +5.5%N/A9252 $25.38
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
9/30/20231,754,100 shares $47.36 million -1.1%N/A17541 $27.00
9/15/20231,774,300 shares $47.91 million -0.1%N/A17743 $27.00
8/31/20231,775,300 shares $47.93 million +0.1%N/A1894.6 $27.00
8/15/20231,774,500 shares $46.94 million +0.1%N/A4436.3 $26.45
7/31/20231,773,300 shares $46.90 million +13.1%N/A479.3 $26.45
7/15/20231,567,500 shares $36.24 million 0.0%N/A1045 $23.12
6/30/20231,567,700 shares $36.21 million -8.0%N/A7838.5 $23.10
6/15/20231,703,900 shares $40.89 million +0.4%N/A8519.5 $24.00
5/31/20231,697,100 shares $39.03 million -0.3%N/A5657 $23.00
5/15/20231,702,000 shares $38.96 million -0.7%N/A17020 $22.89
4/30/20231,714,200 shares $39.72 million +0.4%N/A2857 $23.17
4/15/20231,707,400 shares $35.24 million +11.9%N/A17074 $20.64
3/31/20231,526,500 shares $30.94 million -2.7%N/A1908.1 $20.27
3/15/20231,569,000 shares $32.38 million -0.2%N/A2241.4 $20.64
2/28/20231,571,400 shares $33.20 million +0.3%N/A3928.5 $21.13
2/15/20231,567,000 shares $32.67 million -0.9%N/A3134 $20.85
1/31/20231,580,400 shares $29.82 million +0.6%N/A0 $18.87
1/15/20231,571,500 shares $29.65 million -0.6%N/A0 $18.87
12/30/20221,581,500 shares $29.84 million +0.0%N/A3953.8 $18.87
12/15/20221,581,200 shares $29.84 million -0.1%N/A15812 $18.87
11/30/20221,582,800 shares $22.62 million -0.3%N/A3165.6 $14.29
11/15/20221,588,000 shares $22.69 million +0.3%N/A15880 $14.29
10/31/20221,582,900 shares $22.62 million +0.2%N/A3165.8 $14.29
10/15/20221,579,400 shares $22.55 million +0.4%N/A493.6 $14.28
9/30/20221,572,800 shares $21.64 million +0.2%N/A1966 $13.76
9/15/20221,569,100 shares $23.32 million +114.5%N/A412.9 $14.86
8/31/2022731,700 shares $10.87 million No ChangeN/A385.1 $14.86
8/15/2022731,700 shares $14.20 million +0.5%N/A7317 $19.41
7/31/2022727,800 shares $14.62 million +0.5%N/A7278 $20.09
7/15/2022724,400 shares $14.22 million +54.8%N/A2414.7 $19.63
6/30/2022468,100 shares $8.51 million +0.3%N/A173.4 $18.19
6/15/2022466,700 shares $9.72 million +16.2%N/A4667 $20.82
5/31/2022401,700 shares $8.36 million +3,454.9%N/A0 $20.82
5/15/202211,300 shares $235.27 thousand -86.6%N/A4.7 $20.82
4/30/202284,600 shares $2.37 million -1.7%N/A282 $28.00
4/15/202286,100 shares $2.41 million -1.3%N/A861 $28.00
3/31/202287,200 shares $2.44 million +87.1%N/A79.3 $28.00
3/15/202246,600 shares $1.13 million +639.7%N/A66.6 $24.30
2/28/20226,300 shares $176.40 thousand -19.2%N/A21 $28.00
2/15/20227,800 shares $210.60 thousand -41.8%N/A78 $27.00
1/31/202213,400 shares $361.13 thousand -1.5%N/A33.5 $26.95
1/15/202213,600 shares $384.20 thousand -26.5%N/A34 $28.25
12/31/202118,500 shares $529.84 thousand -66.5%N/A46.3 $28.64
12/15/202155,200 shares $1.60 million +1,477.1%N/A276 $28.92
11/30/20213,500 shares $112 thousand +169.2%N/A35 $32.00
11/15/20211,300 shares $41.60 thousand +44.4%N/A13 $32.00
10/29/2021900 shares $28.80 thousand -35.7%N/A9 $32.00
10/15/20211,400 shares $44.80 thousand +7.7%N/A14 $32.00
9/30/20211,300 shares $44.53 thousand -23.5%N/A13 $34.25
9/15/20211,700 shares $58.31 thousand -97.8%N/A17 $34.30
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
8/31/202177,600 shares $2.66 million -72.7%N/A388 $34.30
8/13/2021284,000 shares $9.94 million -13.2%N/A946.7 $35.00
7/30/2021327,200 shares $11.99 million -11.1%N/A218.1 $36.65
7/15/2021368,000 shares $12.69 million -31.2%N/A613.3 $34.49
6/30/2021534,900 shares $17.65 million +1.5%N/A2674.5 $33.00
6/15/2021526,900 shares $18.05 million +11.8%N/A50.7 $34.25
5/28/2021471,200 shares $16.44 million -11.3%N/A785.3 $34.90
5/14/2021530,900 shares $17.20 million +1.9%N/A1327.3 $32.39
4/30/2021520,800 shares $17.37 million +71.7%N/A1041.6 $33.35
4/15/2021303,400 shares $10.01 million -19.7%N/A505.7 $33.00
3/31/2021377,700 shares $11.65 million -26.6%N/A1259 $30.85
3/15/2021514,700 shares $16.32 million +3.1%N/A735.3 $31.70
2/26/2021499,200 shares $16.27 million -0.8%N/A1664 $32.60
2/12/2021503,000 shares $16.10 million +90.2%N/A628.8 $32.00
1/29/2021264,500 shares $9.06 million +3.1%N/A661.3 $34.25
1/15/2021248,500 shares $8.80 million +5.2%N/A1242.5 $35.40
12/31/2020248,500 shares $8.54 million No ChangeN/A2485 $34.38
12/15/2020248,500 shares $8.41 million +5.2%N/A1242.5 $33.85
11/30/2020236,300 shares $8.24 million -0.5%N/A94.5 $34.86
11/15/2020237,500 shares $8.13 million +1.8%N/A593.8 $34.23
10/30/2020233,400 shares $7.92 million -20.9%N/A1167 $33.93
10/15/2020295,100 shares $10.33 million -0.5%N/A491.8 $35.00
9/30/2020296,700 shares $9.71 million +0.7%N/A185.4 $32.73
9/15/2020294,700 shares $10.17 million -9.6%N/A50.8 $34.50
8/31/2020326,000 shares $10.17 million -41.6%N/A296.4 $31.19
8/14/2020558,500 shares $16.25 million +16.6%N/A797.9 $29.10
7/31/2020479,200 shares $13.23 million +2.6%N/A1597.3 $27.60
7/15/2020467,000 shares $12.38 million +5.7%N/A311.3 $26.50

HKMPF Short Interest - Frequently Asked Questions

What is Hikma Pharmaceuticals' current short interest?

Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 349,300 shares of HKMPF short. 0.16% of Hikma Pharmaceuticals' shares are currently sold short. Learn More on Hikma Pharmaceuticals' current short interest.

What is a good short interest ratio for Hikma Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HKMPF shares currently have a short interest ratio of 873.0. Learn More on Hikma Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Hikma Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.16% of Hikma Pharmaceuticals' floating shares are currently sold short.

Is Hikma Pharmaceuticals' short interest increasing or decreasing?

Hikma Pharmaceuticals saw a drop in short interest in June. As of June 15th, there was short interest totaling 349,300 shares, a drop of 46.1% from the previous total of 648,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Hikma Pharmaceuticals' short interest compare to its competitors?

0.16% of Hikma Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "med - drugs" compare to Hikma Pharmaceuticals: Sandoz Group AG Sponsored ADR (0.01%), Merck KGaA (0.01%), Summit Therapeutics PLC (27.22%), Shionogi & Co., Ltd. Unsponsored ADR (0.01%), United Therapeutics Corporation (3.66%), Neurocrine Biosciences, Inc. (3.71%), Orion OYJ Unsponsored ADR (0.00%), IPSEN (0.00%), Corcept Therapeutics Incorporated (13.49%), Stevanato Group S.p.A. (4.74%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Hikma Pharmaceuticals stock?

Short selling HKMPF is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Hikma Pharmaceuticals?

A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPF, which in turn drives the price of the stock up even further.

How often is Hikma Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPF, twice per month. The most recent reporting period available is June, 15 2025.




This page (OTCMKTS:HKMPF) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners